[1]Rand JH. The annexinopathies: a new category of diseases[J]. Arch Oncol, 2006, 14 (12):23-25.
[2]Chen X, Gao FL, Chang YZh, et al. Expression of ANXA7 in human uterine cervical squamous carcinomas and normal tissues[J]. Acta Anatomica Sinica, 2010,41(4):603-605. (in Chinese)
陈雪,高福禄,常彦忠,等. 膜联蛋白A7在人宫颈鳞癌和正常组织的表达[J]. 解剖学报,2010,41(4):603-605.
[3]Li X, Chen X, Wang XJ, et al. Influence of annexin A7 low expression on proliferation and apoptosis of HeLa cells[J]. Acta Anatomica Sinica, 2010, 41(4):572-575. (in Chinese)
李欣,陈雪,王小杰,等. 膜联蛋白A7低表达对人宫颈癌HeLa细胞系增殖与凋亡的影响[J]. 解剖学报,2010,41(4):572-575.
[4]Wang XJ, Li X. Influence of annexin A7 low expression on proliferation of HepG2 cells [J]. Acta Anatomica Sinica, 2013, 44(5): 656-660. (in Chinese)
王小杰,李欣. 膜联蛋白A7低表达对人肝癌HepG2细胞增殖的影响[J]. 解剖学报,2013,44(5): 656-660.
[5]Srivastava M, Bubendorf L, Srikantan V, et al. ANX7, a candidate tumor suppressor gene for prostate cancer[J]. Proc Natl Acad Sci USA, 2001,98(8):4575-4580.
[6]Hsu PI, Huang MS, Chen HC,et al. The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer[J]. J Surg Oncol, 2008, 97(7):609-614.
[7]Leighton X, Srikantan V, Pollard HB. Significant allelic loss of ANX7region (10q21) in hormone receptor negative breast carcinomas[J]. Cancer Lett, 2004,210(2):239-244.
[8]Kataoka TR, Ito A, Asada H,et al. Annexin VII as a novel marker for invasive phenotype of malignant melanoma[J]. Jpn J Cancer Res, 2000, 91(1):75-83.
[9]Hung KS, Howng SL. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans[J]. J Neurosurg, 2003,99(5):886-892
[10]Yadav AK, Renfrow JJ, Scholtens DM,et al. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factorsignaling in glioblastomas[J]. JAMA, 2009,302(3):276-289.
[11]Srivastava M, Montagna C, Leighton X,et al. Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instabilitypromotes tumorigenesis in the Anx7(+/-) mouse[J].Proc Natl Acad Sci, 2003,100(24):14287-14292.
[12]Srivastava M, Bubendorf L, Raffeld M, et,al. Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients[J]. Clin Cancer Res, 2004, 10(7):2344-2350.
[13]Qazi AS, Sun M, Huang Y, et al. Subcellular proteomics: determination of specific location and expression levels of lymphatic metastasis associated proteins in hepatocellular carcinoma by subcellular fractionation[J]. Biomed Pharmacother, 2011, 65(6):407-416.
[14]Sun MZ, Liu S, Tang J, et,al. Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis[J]. Proteomics, 2009, 9(12):3285-3302.
[15]Wongkham S, Junking M, Wongkham C,et al. Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma[J]. Cancer Sci, 2009,100(11):2077-2084.
[16]Wang YG, Kim SJ, Baek JH, et al. Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression[J]. Exp Mol Med, 2012, 44(6):387-393.
[17]Yu F, Finley RL Jr, Raz A,et al. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c releasefrom the mitochondria. A role for synexin in galectin-3 translocation[J]. J Biol Chem, 2002, 277(18):15819-15827.
|